Evolving global pharmacovigilance regulations have recently put the spot-light on finding better and quicker ways to measure and assess medicinal product benefit-risk profiles through new requirements and guidelines. 

Quintiles can help you better understand and comply with these changing regulations through our safety aggregate reporting and benefit-risk assessment capabilities. Through our experienced staff, best-in-class processes, and proprietary technology, we are able to deliver medical, scientific and regulatory reports that are timely, insightful, and stand up to regulatory scrutiny.